期刊文献+

骨桥蛋白和基质金属蛋白酶-9对经皮冠状动脉介入治疗后支架内再狭窄的诊断价值 被引量:7

The Diagnostic Value of Combined Detection of Osteopontin and Matrix Metalloproteinase-9 for In-stent Restenosis in Patients After Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的 :探讨血清骨桥蛋白(OPN)及金属基质蛋白酶-9(MMP-9)水平变化对经皮冠状动脉介入治疗(PCI)后支架内再狭窄(ISR)的诊断价值。方法 :选择142例于我院接受PCI后复查冠状动脉造影检查的患者,根据冠状动脉造影结果分为再狭窄组(n=21)和无再狭窄组(n=121),复查冠状动脉造影时检测两组患者血清OPN、MMP-9等生化指标,比较两组患者临床资料、OPN及MMP-9等临床生化指标水平。结果:再狭窄组患者血清OPN及MMP-9水平显著高于无再狭窄组,差异有显著统计学意义(P<0.001);Logistic多因素回归分析显示,OPN及MMP-9升高均是PCI后ISR发生的独立危险因素[优势比(OR)=3.034及OR=2.861,P<0.01];在OPN及MMP-9预测ISR能力的受试者工作曲线(ROC)中,其曲线下面积为0.821及0.887,P<0.001;当OPN及MMP-9分别取3.68 ng/ml和415.24 ng/ml时,联合检测可增加检测的敏感性(90.48%)和阴性预测价值(98.06%)。结论:PCI后患者血清OPN及MMP-9水平与ISR密切相关,联合检测血清OPN及MMP-9水平对ISR的发生具有一定的预测价值,尤其是其阴性预测价值。 Objective: To explore the diagnostic value of combined detection of blood osteopontin(OPN) and matrix metalloproteinase-9(MMP-9) for in-stent restenosis(ISR) in patients after percutaneous coronary intervention(PCI).Methods: A total of 142 patients who received post-PCI coronary angiography(CAG) in our hospital were studied. The patients were divided into 2 groups based on if there were ISR condition: ISR group, n=21and Non-ISR group, n=121. The blood levels of OPN and MMP-9 were detected upon the follow-up CAG conduction and the basic clinical information with biochemical indexes were compared between 2 groups.Results: Blood levels of OPN and MMP-9 were significantly higher in ISR group than those in Non-ISR group, P〈0.001. Multivariate logistic regression analysis revealed that elevated levels of OPN and MMP-9 were the independent risk factors for post-PCI ISR occurrence(OR=2.861 and OR=3.343, P〈0.01). The ROC area of OPN and MMP-9 for predicting post-PCI ISR occurrence were 0.821 and 0.887, P〈0.001. Taking the optimal cut off value of OPN at 3.68 ng/ml and MMP-9 at 415.24 ng/ml, the combined detection could increase the sensitivity of detection(90.48%) and the negative predictive value(98.06%).Conclusion: Blood levels of OPN and MMP-9 are closely related to ISR occurrence in post-PCI patients, combined detection has certain predictive value for ISR occurrence, especially for negative predictive value.
出处 《中国循环杂志》 CSCD 北大核心 2015年第7期635-638,共4页 Chinese Circulation Journal
关键词 经皮冠状动脉介入治疗 支架内再狭窄 骨桥蛋白 金属基质蛋白酶-9 联合检测 Percutaneous coronary intervention In-stent restenosis Osteopontin Matrix Metalloproteinase-9 Combined detection
  • 相关文献

参考文献13

  • 1Remus EW, Lyle AN, Weiss D, et al. miR181a protects against angiotensin lI-induced osteopontin expression in vascular smooth muscle cells. Atherosclerosis, 2013, 228: 168-174.
  • 2黄文军,刘俊明,高霞,谢伟,李科,王明建,赵亮,邹琦.血清基质金属蛋白酶-2(MMP-2)和MMP-9与急性冠状动脉综合征的相关研究[J].中国循环杂志,2013,28(2):103-106. 被引量:29
  • 3Vaquerizo B, Serra A, Miranda-Guardiola F, et al. One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from spanish muhicenter registry. Interv Cardiol, 2011, 24:518-528.
  • 4张文广,裴汉军,吴永健,杨跃进,乔树宾,陈纪林,秦学文,陈珏,姚民,刘海波,尤士杰,袁晋青,戴军,高润霖.药物洗脱支架治疗糖尿病合并冠状动脉支架内再狭窄远期疗效及安全性观察[J].中国循环杂志,2013,28(2):96-99. 被引量:19
  • 5Liu D, Cui W, Liu B, et al. Atorvastatin protects vascular smooth muscle cells from TGF-13 1-stimulated calcification by inducing autophagy via suppression of the [3 -catenin pathway. Cell Physiol Biochem, 2014, 33: 129-141.
  • 6路雅茹,于珍,李广平.老年患者血小板衍生生长因子-B与支架内再狭窄的关系[J].中华老年医学杂志,2014,33(2):138-142. 被引量:7
  • 7Liu QF, Yu HW, You L, et al. Apelin-13-induced proliferation and migration induced of rat vascular smooth muscle cells is mediated by the upregulation of Egr-1. Biochem Biophys Res Commun, 2013, 439: 235-240.
  • 8刘志江,石蓓,许官学,等.血管内皮生长因子预防血管成形术后再狭窄的机制.中国动脉硬化杂志,2013,21:22—27.
  • 9Kang SJ, Mintz GS, Park DW, et al. Mechanisms of in-Stent restenosis after drug-eluting stent implantation intravascular ultrasound analysis. Circ Cardiovasc Interv, 2011, 4: 9-14.
  • 10Li XD, Chen J, Ruan CC, et al. Vascular endothelial growth factor- induced osteopontin expression mediates vascular inflammation and neointima formation via Flt-1 in adventitial fibroblasts. Arterioscler Thromb Vasc Biol, 2012, 32: 2250-2258.

二级参考文献47

  • 1陈样新,傅国胜,徐耕,单江.急性冠状动脉综合征患者血清基质金属蛋白酶2的变化[J].中国动脉硬化杂志,2005,13(3):363-366. 被引量:7
  • 2Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Phamacol, 2008, 75: 346-359.
  • 3Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res, 2003, 92: 827-839.
  • 4Katsaros KM, Kastl SP, Zorn G, et al. Increase restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase 2 and -9. JACC Cardiovasc Interv, 2010, 3: 90-97.
  • 5Ge JB, Shen CX, Liang C, et al. Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis. Int J Cardiol, 2006, 112: 85-90.
  • 6Roque M,John T, Juan FJ, et al. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vascr Biol, 2000,20 : 335-342.
  • 7Scott NA. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury. Adv Drug Deliv Rev, 2006,58: 358-376.
  • 8Li C, Wernig F, Leitges M, et al. Mechanical stress-activated PKC delta regulates smooth muscle migration. FASEB J, 2003, 17: 2106-2108.
  • 9Eitges M, Mayr M, Braun U, et al. Exacerbated vein graft arteriosclerosis in protein kinase C delta mice. J ClinInvest, 2001, 108: 1505-1512.
  • 10Hong SJ, Kim MH, Ahn TH, et al. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes. Heart, 2006, 92:1119-1124.

共引文献55

同被引文献82

  • 1张赟建,殷恒讳,姚陈,叶财盛,叶润仪,常光其,王深明.肿瘤坏死因子α对深静脉血栓形成大鼠的静脉内皮细胞功能的影响[J].中国血管外科杂志(电子版),2011,3(3):173-177. 被引量:5
  • 2朱华庆,程筱雯,张慧,周青,桂淑玉,汪渊.高脂血症对大鼠动脉肌球蛋白轻链激酶活性及表达的影响[J].安徽医科大学学报,2005,40(6):504-507. 被引量:3
  • 3无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2079
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2149
  • 5Charles T.Esmon.The interactions between inflammation and coagulation[J]. British Journal of Haematology . 2005 (4)
  • 6Randriamboavonjy Voahanginirina,Isaak Johann,Elgheznawy Amro,Pistrosch Frank,Fr?mel Timo,Yin Xiaoke,Badenhoop Klaus,Heide Heinrich,Mayr Manuel,Fleming Ingrid.Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes. Blood . 2012
  • 7Tadie JM,Bae HB,Jiang S, et al.HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4. American Journal of Physiology Lung Cellular and Molecular Physiology . 2013
  • 8Kikuo Isoda,Kenichirou Nishikawa,Yashuhiro Kamezawa,Mikoto Yoshida,Masatoshi Kusuhara,Masao Moroi,Norihiro Tada,Fumitaka Ohsuzu.??Osteopontin Plays an Important Role in the Development of Medial Thickening and Neointimal Formation(J)Circulation Research: Journal of the American Heart Association . 2002 (1)
  • 9V.S. Reddy,G.B. Reddy.??Emerging Role for ?B-Crystallin as a Therapeutic Agent: Pros and Cons(J)Current Molecular Medicine . 2015 (1)
  • 10Yukiko Enomoto,Seiji Adachi,Rie Matsushima-Nishiwaki,Masayuki Niwa,Haruhiko Tokuda,Shigeru Akamatsu,Tomoaki Doi,Hisaaki Kato,Shinichi Yoshimura,Shinji Ogura,Toru Iwama,Osamu Kozawa.??αB-crystallin extracellularly suppresses ADP-induced granule secretion from human platelets(J)FEBS Letters . 2009 (15)

引证文献7

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部